European Patent Application 95 30 5602.5, pages 1-29

dc.contributor.advisor
dc.contributor.author

Skolnick, Mark H.

dc.contributor.author

Goldgar, David E.

dc.contributor.author

Miki, Yoshio

dc.contributor.author

Swenson, Jeff

dc.contributor.author

Kamb, Alexander

dc.contributor.author

Harshman, Keith D.

dc.contributor.author

Shattuck-Eidens, Donna M.

dc.contributor.author

Tavtigian, Sean V.

dc.contributor.author

Wiseman, Roger W.

dc.contributor.author

Futreal, P. Andrew

dc.date.accessioned

2013-07-16T01:23:39Z

dc.date.available

2013-07-16T01:23:39Z

dc.date.issued

1995-11-08

dc.description

European patent application 95 30 5602.5, filed by inventors affiliated with Myriad Genetics, Inc., the University of Utah Research Foundation, and the National Institutes of Health

dc.identifier.uri

https://hdl.handle.net/10161/7670

dc.language.iso

en_US

dc.subject

Genetics, Myriad Genetics, BRCA, Breast Cancer, Gene Patents, Law, Health Policy, Medicine, Women’s Health

dc.title

European Patent Application 95 30 5602.5, pages 1-29

dc.type

Other

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Myriad.epo application pp 1 to 29.1995.pdf
Size:
2.03 MB
Format:
Adobe Portable Document Format
Description:
Myriad EPO application, pp. 1-25
Loading...
Thumbnail Image
Name:
Myriad.epo application pp 30 to 55.1995.pdf
Size:
1.33 MB
Format:
Adobe Portable Document Format
Description:
Myriad EPO Application, pp. 30-55